FluoSphera develops Liquid Microphysiological Systems to better predict the efficacy and safety of candidate drugs with an unprecedented multiplexing capacity. Our LMSs allow pharmaceutical companies to de-risk their drug discovery pipelines much earlier, thus decreasing their costs of failure.


Route de la Galaise 34, 1228 Plan-les-Ouates, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland